Boston Scientific Corporation Common Stock (BSX)
Stock · NYSE · Health Care
$46.84as of 8/28/2026
Price chart
Open in TradingViewActive signals
About BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scop…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 59,000
Fundamentals
- 1-day range
- $46.51$47.22
- Market cap
- $71.98B
- P/E (trailing)
- 20.40
- P/E (forward)
- 13.64
- EPS (trailing)
- $2.47
- Dividend yield
- —
- Beta
- 0.57
- Avg. volume
- 20.39M
How Boston Scientific Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 17, 2026 · via SEC EDGAR / Finnhub
Forecasts
29 analyst ratings
Boston Scientific Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- BSXBoston Scientific Corporation Common Stock$46.83▲ 0.34%Market cap $71.98BP/E 20.40$42.2$109.5
- MDLNMedline Inc. Class A Common Stock$35.29▲ 1.85%Market cap $53.16BP/E 67.50$32.49$50.88
- BDXBecton Dickinson and Company Common Stock$189.6▲ 0.78%Market cap $46.90BP/E 53.21$127.59$193.07
- DXCMDexCom Inc. Common Stock$90.8▲ 1.69%Market cap $32.95BP/E 34.53$54.11$92.59
- RMDResMed Inc. Common Stock$240.24▲ 1.90%Market cap $31.21BP/E 21.47$180.27$285.08
- BAXBaxter International Inc. Common Stock$26.12▲ 0.77%Market cap $14.53BP/E —$15.73$30
- SYKStryker Corporation Common Stock$330.67▲ 2.65%Market cap $130.80BP/E 35.17$281$396.86
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BSX Boston Scientific Corporation Common Stock | $71.98B | 20.40 | $46.83 | ▲ 0.34% | $42.2$109.5 |
| MDLN Medline Inc. Class A Common Stock | $53.16B | 67.50 | $35.29 | ▲ 1.85% | $32.49$50.88 |
| BDX Becton Dickinson and Company Common Stock | $46.90B | 53.21 | $189.6 | ▲ 0.78% | $127.59$193.07 |
| DXCM DexCom Inc. Common Stock | $32.95B | 34.53 | $90.8 | ▲ 1.69% | $54.11$92.59 |
| RMD ResMed Inc. Common Stock | $31.21B | 21.47 | $240.24 | ▲ 1.90% | $180.27$285.08 |
| BAX Baxter International Inc. Common Stock | $14.53B | — | $26.12 | ▲ 0.77% | $15.73$30 |
| SYK Stryker Corporation Common Stock | $130.80B | 35.17 | $330.67 | ▲ 2.65% | $281$396.86 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Boston Scientific (NYSE:BSX) Stands Out as a Quality InvestmentChartMill · 8/27/2026
- Thursday's big stock stories: What’s likely to move the market in the next trading sessionCNBC · 8/26/2026
- What's going on in today's session: S&P500 moversChartMill · 8/26/2026
- Boston Scientific Reports Global Disruption After Cybersecurity Incidentbenzinga · 8/26/2026
- Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session.ChartMill · 8/26/2026
- These S&P500 stocks are gapping in today's sessionChartMill · 8/26/2026
- Boston Scientific Reports Global Disruption After Cybersecurity IncidentBenzinga · 8/26/2026
- Nasdaq 100 Falls as Hot PCE Inflation Stirs Rate-Hike Bets: Stock Market TodayBenzinga · 8/26/2026
- Top S&P500 movers in Wednesday's pre-market sessionChartMill · 8/26/2026
Insider Activity
Insider Actions →- Susan E. Morano · August 25, 2026 · Buy2.0K @ $49.22
- Emily Woodworth · August 11, 2026 · I2.9K @ $51.19
- Jonathan Monson · August 10, 2026 · I9.9K @ $50.46
- David C. Habiger · August 5, 2026 · Buy2.1K @ $47.59
- David C. Habiger · August 4, 2026 · Buy140 @ $48.59
- Michael F. Mahoney · August 3, 2026 · I22.1K @ $48.43
- Michael F. Mahoney · August 3, 2026 · Buy186.2K @ $48.33
- David C. Habiger · August 3, 2026 · Buy1.0K @ $48.07
- Joseph Michael Fitzgerald · July 31, 2026 · I64.2K @ $46.73
- Edward J. Ludwig · July 31, 2026 · Buy5.0K @ $45.48
- Jonathan Monson · July 1, 2026 · Option Exercise2.1K
- Jonathan Monson · July 1, 2026 · Tax Withholding1.0K @ $43.06
- Michael F. Mahoney · May 28, 2026 · Gift386.8K
- Cheryl Pegus · May 20, 2026 · Buy1.8K @ $56.49
- David C. Habiger · May 20, 2026 · Buy2.3K @ $55.92
Institutional Ownership
March 31, 2026
- Total shares held
- 1.29B
- Total value held
- $78.05B
- Institutional holders
- 1650
- Unknown131.82M
- Unknown96.41M
- Unknown74.23M
- Unknown67.99M
- Unknown33.29M
- Unknown32.53M
- Unknown24.43M
- Unknown22.76M
- Unknown22.27M
- Unknown19.37M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedSynthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
August 29, 2026
BSX Faces Cybersecurity Disruption as Broader Market Pressure Builds. Boston Scientific disclosed a global disruption tied to a cybersecurity incident, drawing market attention to the medical device maker on an otherwise difficult day for equities. Broader market jitters, including renewed rate-hike concerns following a hot PCE inflation reading, weighed on sentiment, yet BSX was also flagged among notable S&P 500 movers and gapping stocks. Separately, an independent screen highlighted BSX as a quality name, though the company was navigating operational headwinds from the cyber event at the time. The combination of company-specific news and macro pressure made the stock one of the more actively discussed names in recent sessions.